← FDA DRUG APPROVALS

FDA ANDA · ANDA076460

IBUPROFEN

Sponsor: AVEMA PHARMA

APPLICATION
ANDA076460
TYPE
ANDA
ORIGINAL APPROVAL
2003-11-26
LATEST ACTION
2014-11-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter

Products

IBUPROFENOver-the-counter
IBUPROFEN 200MG · TABLET · ORAL

Approval history

2014-11-20Manufacturing (CMC) · Supplement 7AP
2014-11-03Labeling · Supplement 6AP
2014-07-10Labeling · Supplement 4AP
2003-11-26OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →